Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa

NCT02626286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 885

Last updated 2026-04-15

No results posted yet for this study

Summary

The objective of the study is to evaluate the feasibility and interest of a HIV quarterly preventive global care for men who have sex with men (MSM) in sub-Saharan Africa to help reducing HIV incidence in this key population, their female partners, and the general population. This interventional, open label, multicenter, multidisciplinary cohort study will be conducted in Burkina Faso, Ivory Coast, Mali and Togo.

All participants will receive a HIV quarterly preventive global care including:

i) data collection on health status, symptoms of sexually transmitted infections (STI) and sexual behavior, ii) a clinical examination, iii) STI diagnosis and treatment, iv) counselling adapted for MSM, and v) the provision of condoms and lubricants.

Conditions

  • HIV Infection

Interventions

OTHER

HIV quarterly global care

Sponsors & Collaborators

  • Expertise France

    collaborator OTHER
  • Université Montpellier

    collaborator OTHER
  • IRD Unité SESSTIM (IRD, Inserm, Université Aix-Marseille)

    collaborator UNKNOWN
  • Coalition Internationale Sida

    collaborator OTHER
  • ARCAD-SIDA MALI

    collaborator OTHER
  • Espace Confiance, Côte d'Ivoire

    collaborator OTHER
  • Programme PAC-CI, Abidjan, Côte d'Ivoire

    collaborator UNKNOWN
  • Association African Solidarité

    collaborator OTHER
  • Centre de Recherche Internationale pour la Santé, Ouagadougou, Burkina Faso

    collaborator UNKNOWN
  • Espoir Vie-Togo - ONG

    collaborator OTHER
  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-01-05
Completion
2021-01-05

Countries

  • Burkina Faso
  • Côte d’Ivoire
  • Mali
  • Togo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626286 on ClinicalTrials.gov